GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » Return-on-Tangible-Equity

Hims & Hers Health (Hims & Hers Health) Return-on-Tangible-Equity : 20.69% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Hims & Hers Health's annualized net income for the quarter that ended in Mar. 2024 was $44.5 Mil. Hims & Hers Health's average shareholder tangible equity for the quarter that ended in Mar. 2024 was $215.2 Mil. Therefore, Hims & Hers Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 20.69%.

The historical rank and industry rank for Hims & Hers Health's Return-on-Tangible-Equity or its related term are showing as below:

HIMS' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -422.9   Med: -34.85   Max: -1.18
Current: -1.18

During the past 5 years, Hims & Hers Health's highest Return-on-Tangible-Equity was -1.18%. The lowest was -422.90%. And the median was -34.85%.

HIMS's Return-on-Tangible-Equity is ranked worse than
77.29% of 1792 companies
in the Consumer Packaged Goods industry
Industry Median: 7.755 vs HIMS: -1.18

Hims & Hers Health Return-on-Tangible-Equity Historical Data

The historical data trend for Hims & Hers Health's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health Return-on-Tangible-Equity Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
- - -422.90 -34.85 -11.96

Hims & Hers Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.37 -15.47 -15.62 2.41 20.69

Competitive Comparison of Hims & Hers Health's Return-on-Tangible-Equity

For the Household & Personal Products subindustry, Hims & Hers Health's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health's Return-on-Tangible-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hims & Hers Health's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's Return-on-Tangible-Equity falls into.



Hims & Hers Health Return-on-Tangible-Equity Calculation

Hims & Hers Health's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-23.546/( (179.019+214.574 )/ 2 )
=-23.546/196.7965
=-11.96 %

Hims & Hers Health's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=44.512/( (214.574+215.738)/ 2 )
=44.512/215.156
=20.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Hims & Hers Health  (NYSE:HIMS) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Hims & Hers Health Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hims & Hers Health (Hims & Hers Health) Business Description

Traded in Other Exchanges
Address
2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Executives
Andrew Dudum director, 10 percent owner, officer: Chief Executive Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe officer: Chief Financial Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton officer: See Remarks 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund officer: Interim PFO/PAO 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird officer: Chief Operating Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells director C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz director 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis director 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi officer: Chief Marketing Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham 10 percent owner 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll officer: Chief Medicall Officer 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123